Precision Perspectives: Navigating Advancements in HR+ / HER2 Negative Breast Cancer Care

home / peer-exchange / precision-perspectives-navigating-advancements-in-hr-her2-negative-breast-cancer-care

Ryan Haumschild, PharmD, MS, MBA, leads a panel of experts in a discussion focusing on metastatic breast cancer (mBC) and early breast cancer (eBC), covering the most recent treatment guidelines, drug toxicities, and a comparative analysis of CDK4/6 inhibitors.

© 2024 MJH Life Sciences

All rights reserved.